Satya Marar
-
Visiting Postgraduate Fellow
Satya Marar is a Visiting Postgraduate Fellow at the Mercatus Center at George Mason University where he was formerly an MA Fellow. He holds an MA in Economics from George Mason University and a BA in writing and an LLB with Honors in law from Macquarie University in Sydney, Australia. He is currently pursuing an LLM in US law at George Mason University. He has previously worked at Reason Foundation and the Australian Taxpayers’ Alliance. His research interests include antitrust & competition policy, intellectual property, trade and technology policy.
Latest Work
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
A Pragmatic Antitrust Vision for the New Administration | The Hill
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Key Antitrust Developments in 2024 and Prospects for the Coming Year | IPWatchdog
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Antitrust Under Trump 2.0: Competition Corner
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Requiem for a Neo-Brandeisian Dream | Competition Corner
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
FTC’s Lawsuit Against PBMs Over Insulin Prices Misses the Mark | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Who’s Really To Blame for Drug Prices? | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Tariffs’ Biggest Casualties — Workers and Manufacturing | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Government Overreach Won’t Help Wisconsin Patients | The Center Square
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
When It Comes to Artificial Intelligence, ‘Big Data’ Isn’t Everything | Discourse
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
The FTC Case Against PBM Rebates | Truth on the Market
Latest Work
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
A Pragmatic Antitrust Vision for the New Administration | The Hill
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Key Antitrust Developments in 2024 and Prospects for the Coming Year | IPWatchdog
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Antitrust Under Trump 2.0: Competition Corner
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Requiem for a Neo-Brandeisian Dream | Competition Corner
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
FTC’s Lawsuit Against PBMs Over Insulin Prices Misses the Mark | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Who’s Really To Blame for Drug Prices? | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Tariffs’ Biggest Casualties — Workers and Manufacturing | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Government Overreach Won’t Help Wisconsin Patients | The Center Square
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
When It Comes to Artificial Intelligence, ‘Big Data’ Isn’t Everything | Discourse
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
The FTC Case Against PBM Rebates | Truth on the Market
Latest Work
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
Unintended Consequences: The Real Effects of Populist Antitrust Policies on Competition and Small Enterprises
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
Proceedings of the 2024 Annual Mercatus Center Antitrust Forum
- | Antitrust and Competition Antitrust and Competition
- | Research Papers Research Papers
Artificial Intelligence and Antitrust Law: A Primer
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
Antitrust Enforcement in 2023: Year in Review for the Federal Trade Commission and the Department of Justice
- | Antitrust and Competition Antitrust and Competition
- | Policy Briefs Policy Briefs
The Robinson-Patman Act: A Statute at Odds with Competition and Economic Welfare
Latest Work
- | Antitrust and Competition Antitrust and Competition
- | Public Interest Comments Public Interest Comments
The European Commission's Draft "Proposal for a Regulation of the European Parliament and of the Council on Standard Essential Patents" is Unnecessary and Harmful
Latest Work
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
A Pragmatic Antitrust Vision for the New Administration | The Hill
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Key Antitrust Developments in 2024 and Prospects for the Coming Year | IPWatchdog
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Antitrust Under Trump 2.0: Competition Corner
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Requiem for a Neo-Brandeisian Dream | Competition Corner
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
FTC’s Lawsuit Against PBMs Over Insulin Prices Misses the Mark | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Who’s Really To Blame for Drug Prices? | Competition Corner (Substack)
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Tariffs’ Biggest Casualties — Workers and Manufacturing | DC Journal and InsideSources
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
Government Overreach Won’t Help Wisconsin Patients | The Center Square
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary
When It Comes to Artificial Intelligence, ‘Big Data’ Isn’t Everything | Discourse
- | Antitrust and Competition Antitrust and Competition
- | Expert Commentary Expert Commentary